Bharat Dynamics Q4 Profit Plunges 59 to Rs 113 Crore Board Recommends Dividend Surging Gas Prices Disproportionately Squeeze LowerIncome Households New York Fed Study Suggests Could SpaceX Become the Least ShareholderFriendly Public Company Ever BJs Wholesale Club Announces Strategic Store Changes Amid Consumer Spending Shift Hindalco Reports 50 Drop in Q4 Net Profit Due to OneTime Expense of 4171 Crore at Novelis Money Market Account Rates on May 25 2026 Top Yields Reach 401 APY ELV Q1 2026 Earnings Strong Earnings Beat Overshadowed by Stock Decline Hut 8 Corp Q3 2024 Earnings Narrows Loss Expectancy with EPS Beat LUMN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing Transformation Challenges SOJF Q1 2026 Earnings Solid EPS Beat Highlights Resilient Utility Performance Landstar System LSTR Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue SREA Holds Steady Near 2120 as FixedIncome Investors Eye Yield HCACR Holds Steady at 029 Hall Chadwick Acquisition Corp Rights in Tight Trading Range Pennant Group Inc PNTG Slides 194 Key Support Levels Under Scrutiny Sagimet Biosciences SGMT Gains 129 as Shares Test Key Resistance Level CleanSpark CLSK Edges Higher After Recent Volatility Key Levels in Focus LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad Magnite MGNI Q1 2026 Earnings EPS Beats Expectations as AdTech Momentum Continues Immunovant IMVT Edges Lower Amid Consolidation Support and Resistance Levels in Focus Brookfield Business Partners BBU Slips 2 as Stock Nears Key Support Zone Allegro MicroSystems Surges 36 Momentum Builds Toward Key Resistance Spartacus Acquisition Corp II Unit TMTSU Slips Slightly as SPAC Market Remains in Focus Natural Alternatives International NAII Edges Higher as Stock Holds Within Established Range RF Industries RFIL Gains 37 as Stock Approaches Key Resistance at 1945 Aclaris Therapeutics ACRS Edges Higher Testing Key Resistance Near 481 ALX Oncology ALXO Edges Higher Amid Modest Buying Interest Resistance at 206 in Focus